Empire Genomics

Empire Genomics is a molecular diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) and Chromogenic in Situ Hybridization (CISH) probes for clinical diagnostics and research applications. Founded in 2006 by Dr. Norma J. Nowak and based in Depew, New York, the company originated from research at Roswell Park Comprehensive Cancer Institute. Empire Genomics offers a comprehensive portfolio of over 2,000 FISH probes optimized for cancer research, genetic testing across 200+ health conditions, and routine clinical diagnostics. Their product line includes manual and automated FISH probes, break-apart and fusion probes, single and dual-color probes, custom probe design services, and ancillary reagents. The company provides full-service FISH processing with rapid turnaround (next-day shipping for in-stock items; custom designs in two weeks). Empire Genomics supplies 44 of the top 50 US cancer centers and has sold over 1 million tests globally. Quality assurance includes BAC End Sequencing validation and access to a 645K+ clone library. Automation solutions include NeoPATH Pro for tissue, BioDot Cellwriter S for hematology, and ONCORE Pro for urine specimens.